A carregar...

New EMA report on paliperidone 3-month injections: taking clinical and policy decisions without an adequate evidence base

Three-month long-acting paliperidone is a new, recently marketed, formulation of paliperidone, characterised by the longest available dosing interval among long-acting antipsychotics. The clinical profile of 3-month long-acting paliperidone was recently summarised by the European Medicines Agency (E...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Epidemiol Psychiatr Sci
Main Authors: Ostuzzi, G., Papola, D., Gastaldon, C., Barbui, C.
Formato: Artigo
Idioma:Inglês
Publicado em: Cambridge University Press 2016
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6998643/
https://ncbi.nlm.nih.gov/pubmed/28004623
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1017/S2045796016001025
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!